IMNN logo
IMNN NASDAQ US

Imunon, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 1993
$3.22
▲ +$0.23 (+7.69%)
Vol 38K
2
Quality Score
fail
Mkt Cap
$11.7M
ROE
-501.1%
Margin
-6901.9%
D/E
0.00
Beta
2.17
52W
$3–$41

Wall Street Consensus

10 analysts · Apr 2026
2
Strong Buy
6
Buy
2
Hold
0
Sell
0
Strong Sell
80.0%
Buy Rating

Price Chart

Similar Stocks

MBRX
Moleculin Biotech Inc
$6.8M
SNGX
Soligenix Inc
$13.5M
CLRB
Cellectar Biosciences Inc
$12.5M
BIVI
BioVie Inc
$8.7M
ACXP
Acurx Pharmaceuticals Inc
$5.8M
BCAB
Bioatla Inc
$33.5M

Earnings

Beat rate: 80.0%
Next Report May 11, 2026
EPS Estimate: $-1.06
Quarter EPS Est EPS Act Surprise
Mar 2026 $-1.06 — —
Dec 2025 $-1.20 $-2.02 $-0.82
Sep 2025 $-1.84 $-1.16 +$0.68
Jun 2025 $-4.20 $-1.87 +$2.33

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -405.1% -405.1% -405.1% -405.1% -405.1% -501.1%
P/E (TTM) — — — — — —
Net Margin — -6901.9% -6901.9% -6901.9% -6901.9% -6901.9%
Gross Margin — 34.1% 34.1% 34.1% 34.1% 34.1%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 1.30 1.30 1.30 1.30 1.30 1.73

Key Ratios

ROA (TTM)
-166.8%
P/S (TTM)
22.50
P/B
3.2
EPS (TTM)
$-10.20
CF/Share
$-3.05
52W High
$41.22
52W Low
$3.14
$3.14 52-Week Range $41.22

How does IMNN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

IMNN AAPG ABEO ABOS ABP

IMNN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
22.5
▲ 75% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
3.3
▲ 32% above peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

IMNN profitability vs Biotechnology peers

ROE
-501.1%
▼ 645% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-6901.9%
▼ 2307% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
34.1%
▼ 57% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-166.8%
▼ 257% below peers (-46.7%)
vs Peers
vs Industry
Weak

IMNN financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
1.7
▼ 61% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.2
▲ 124% above peers (1.0)
vs Peers
vs Industry
More volatile

IMNN fundamentals radar

IMNN Peer median Industry

IMNN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

IMNN vs peers: key metrics

Latest News

No related news yet